Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Pharmacological Research|August 12, 2019
The new entries in the therapeutic armamentarium: The small molecule JAK inhibitorsKatie Bechman, Mark Yates, James B Galloway
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|January 16, 2020
Defining and measuring imaging appropriateness in low back pain studies: a scoping reviewMark Yates, Crystian B Oliveira, James B Galloway, et al.
Rheumatology Advances in Practice|May 12, 2025
A psychometric evaluation of the Musculoskeletal Health Questionnaire (MSK-HQ): validation and measurement invariance in inflammatory arthritisNikita Arumalla, James B Galloway, Joanna Ledingham, et al.
Annals of the Rheumatic Diseases|March 30, 2018
Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid ArthritisAndrew I Rutherford, Sujith Subesinghe, Kimme L Hyrich, et al.
Rheumatology (Oxford, England)|July 11, 2021
Improving outcomes for patients hospitalized with gout: a systematic reviewMark D Russell, Benjamin D Clarke, Edward Roddy, et al.
The Journal of Rheumatology|May 3, 2019
Placebo Response in Rheumatoid Arthritis Clinical TrialsKatie Bechman, Mark Yates, Sam Norton, et al.
The Journal of Rheumatology|March 17, 2018
A Systematic Review and Metaanalysis of Antirheumatic Drugs and Vaccine Immunogenicity in Rheumatoid ArthritisSujith Subesinghe, Katie Bechman, Andrew I Rutherford, et al.
BMC Rheumatology|December 9, 2020
A systematic review of CXCL13 as a biomarker of disease and treatment response in rheumatoid arthritisKatie Bechman, Anthony Dalrymple, Charles Southey-Bassols, et al.
Rheumatology (Oxford, England)|March 13, 2018
Opportunistic infections in rheumatoid arthritis patients exposed to biologic therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid ArthritisAndrew I Rutherford, Eunice Patarata, Sujith Subesinghe, et al.
Expert Review of Clinical Immunology|December 3, 2021
The infection risks of JAK inhibitionMaryam A Adas, Edward Alveyn, Emma Cook, et al.
Pageof 8